His primary areas of investigation include Internal medicine, Cardiology, Percutaneous coronary intervention, Myocardial infarction and Surgery. His work on Internal medicine is being expanded to include thematically relevant topics such as Endocrinology. His Fractional flow reserve, Cardiac catheterization, Artery and Coronary circulation study in the realm of Cardiology connects with subjects such as Context.
His Percutaneous coronary intervention research is multidisciplinary, relying on both Cardiac surgery and Clinical endpoint, Randomized controlled trial, Clinical trial. Javier Escaned combines subjects such as Intravascular ultrasound and Platelet aggregation inhibitor with his study of Myocardial infarction. His Surgery research integrates issues from Relative risk and Revascularization.
His primary areas of study are Internal medicine, Cardiology, Percutaneous coronary intervention, Fractional flow reserve and Myocardial infarction. His study connects Surgery and Internal medicine. His Percutaneous coronary intervention research incorporates elements of Randomized controlled trial and Conventional PCI.
Javier Escaned has included themes like Coronary stenosis, Angiography, Confidence interval and Aortic pressure in his Fractional flow reserve study. The study incorporates disciplines such as Clinical endpoint and Hazard ratio in addition to Myocardial infarction. His research in Stent intersects with topics in Intravascular ultrasound and Angioplasty.
His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI. Internal medicine is represented through his Revascularization, Coronary artery disease, Mace, Acute coronary syndrome and Hazard ratio research. Javier Escaned works mostly in the field of Cardiology, limiting it down to topics relating to Stent and, in certain cases, Balloon.
The Myocardial infarction study combines topics in areas such as Clinical endpoint, Ejection fraction, Heart failure and Cohort. His study looks at the intersection of Percutaneous coronary intervention and topics like Nuclear medicine with Optical coherence tomography. His research integrates issues of Percutaneous and Randomized controlled trial in his study of Conventional PCI.
Javier Escaned mostly deals with Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Coronary artery disease. His study in Hazard ratio, Randomized controlled trial, Stenosis, Stent and Confidence interval is done as part of Internal medicine. Cardiology is a component of his Revascularization, Conventional PCI, Mace, Acute coronary syndrome and Fractional flow reserve studies.
Javier Escaned interconnects Stroke, Clinical endpoint and Cohort in the investigation of issues within Myocardial infarction. His Percutaneous coronary intervention study integrates concerns from other disciplines, such as Nuclear medicine, Dosimetry, Dose area product and Radiological weapon. His Coronary artery disease research includes elements of Angiography, Surgery, Intensive care medicine, Kissing balloon and Instantaneous wave-free ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Juhani Knuuti;William Wijns;Antti Saraste;Davide Capodanno.
European Heart Journal (2020)
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
pre-diabetes Task Force on diabetes;Lars Rydén.
Diabetes and Vascular Disease Research (2014)
Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis A Randomized Trial
G. Jan Willem Bech;Bernard De Bruyne;Nico H.J. Pijls;Ebo D. de Muinck.
Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study.
Sayan Sen;Javier Escaned;Iqbal S. Malik;Ghada W. Mikhail.
Journal of the American College of Cardiology (2012)
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
Raúl Moreno;Cristina Fernández;Rosana Hernández;Fernando Alfonso.
Journal of the American College of Cardiology (2005)
Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI
J. E. Davies;S. Sen;H. M. Dehbi;H. M. Dehbi;H. M. Dehbi;R. Al-Lamee.
The New England Journal of Medicine (2017)
Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment
Dominick J. Angiolillo;Antonio Fernandez-Ortiz;Esther Bernardo;Celia Ramírez.
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)
Lars Rydén;Peter J. Grant;Stefan D. Anker;Christian Berne.
Revista Espanola De Cardiologia (2014)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Roxana Mehran;Usman Baber;Samin K Sharma;David J Cohen.
The New England Journal of Medicine (2019)
Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial
Manel Sabaté;Pilar Jiménez-Quevedo;Dominick J. Angiolillo;Joan Antoni Gómez-Hospital.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: